CRISPRMED24 Poster Prize Winners
By: Karen O'Hanlon Cohrt - Apr. 29, 2024
- Rodrigo Coronel Tellez, Postdoc at Danish Technical University: Efficient sortase-mediated assembly of CRISPR-Cas9
- Colette Rogers, Postdoc at University of Minnesota: In Vivo Correction of a Genetically Humanized Fanconi Anemia Mouse Model Using Digital Editing Technologies
- Helena Escobar, Postdoc at Max-Delbrück Center - Charite, Berlin: Gene-edited primary muscle stem cells rescue dysferlin-deficient muscular dystrophy
- Federica Zinghirino, Postdoc at University College London: Development of a CRISPR-based epigenome editing platform to enhance the long-term engraftment of ex-vivo genetically modified HSPCs
- Issa Ismail, PhD fellow at Aalborg University, Denmark: Genome-wide CRISPR-Cas9 knockout screen identifies DNA damage response pathways and BTK as essential for cisplatin response in diffuse large B-cell lymphoma
- Laura Castilla-Vallmanya, Postdoc at Lund Stem Cell Centre, Sweden: Studying the role of TRIM28 and transposable elements dysregulation in neurodevelopmental disorders using CRISPRed in vitro models
- Roberta Vacca, PhD student at San Raffaele Telethon Institute for Gene Therapy, Italy: p38 MAPK fuels proliferation stress and DNA damage impairing the functionality of genetically engineered hematopoietic stem and progenitor cells
- Pietro De Angeli, Scientist, University Hospital Tübingen, Germany: EDSpliCE: A Novel Gene Editing Platform Holding Therapeutic Potential for Splicing Modulation in Inherited Retinal Disorders
Tags
CLINICAL TRIALS
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III